Micro Tube Box Market Report 2026

The micro tube box market size has grown steadily in recent years. It will grow from $2.03 billion in 2025 to $2.12 billion in 2026 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to expansion of biotechnology research activities, increasing number of diagnostic laboratories, growth in pharmaceutical R&D, rising use of microcentrifuge tubes, standardization of laboratory storage practices.

The micro tube box market size is expected to see steady growth in the next few years. It will grow to $2.5 billion in 2030 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to increasing investments in life sciences research infrastructure, rising adoption of automated laboratories, expansion of biobanking activities, growing demand for eco-friendly lab consumables, increasing focus on long-term sample integrity. Major trends in the forecast period include increasing demand for high-density sample storage solutions, rising adoption of temperature-resistant tube boxes, growing use of modular and stackable designs, expansion of automated laboratory storage compatibility, enhanced focus on sample traceability and organization.

The increasing volume of diagnostic activities is expected to drive the growth of the micro tube box market in the coming years. Diagnostic activities include medical tests and procedures conducted to detect, evaluate, and monitor diseases, conditions, or injuries in patients. The rise in diagnostic testing is supported by growing demand for early disease identification, advancements in medical technologies, and an increased emphasis on preventive healthcare. Micro tube boxes play an important role in diagnostic workflows by enabling organized storage and safe transportation of small sample tubes, ensuring proper containment and preservation of specimens during laboratory testing and analysis. For example, in May 2023, according to the National Health Service (NHS), a UK-based publicly funded healthcare system, a total of 2,302,400 diagnostic tests were performed in March 2023, representing an increase of 223,100 tests compared with March 2022. Additionally, by the end of March 2023, the number of patients awaiting a key diagnostic test reached 1,628,300, an increase of 59,400 compared with March 2022. Therefore, the growth in diagnostic activities is supporting the expansion of the micro tube box market.

The expansion of personalized medicine is also expected to propel the growth of the micro tube box market going forward. Personalized medicine involves customized medical treatments based on an individual’s genetic makeup, disease profile, or lifestyle characteristics. Adoption of personalized medicine is increasing as genetic testing becomes more widely available, enabling healthcare providers to assess disease risks more accurately and tailor therapies to individual patients. Micro tube boxes support personalized medicine by ensuring the secure, organized handling and storage of patient-specific biological samples, which is critical for precise genetic testing and treatment delivery. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit research organization, the US Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, compared with six approvals in 2022. The 2023 approvals also included seven oncology therapies and three treatments addressing other medical conditions. Therefore, the continued expansion of personalized medicine is driving growth in the micro tube box market.

In May 2023, Calibre Scientific, a US-based provider of life science reagents, acquired a micromanipulation product portfolio from Eppendorf SE for an undisclosed amount. Through this acquisition, Calibre Scientific expanded its portfolio by adding a leading range of micromanipulation and microinjection instruments to its life science solutions offering. Eppendorf SE is a Germany-based manufacturer of microtube boxes.

Major companies operating in the micro tube box market are Thermo Fisher Scientific Inc., Corning Incorporated, DKSH Holding Ltd., VWR International LLC, Thomas Scientific LLC, Chemglass Life Sciences LLC, Westlab Pty Ltd., Tarsons Products Limited, Neta Scientific Inc., The Starlab Group, Next Day Science Inc., Boekel Scientific, Abdos Labtech Private Limited, Analytical Sales and Services Inc., Scientific Industries Inc., Teklab Inc., Labnet International, Heathrow Scientific Inc., Lab Pro Inc., Research Products International Corp., Thistle Scientific Ltd., Boca Scientific Inc.

North America was the largest region in the micro tube box market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the micro tube box market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the micro tube box market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The micro tube box market consists of sales of cryogenic vial boxes, tube racks, centrifuge tube holders, sample transport boxes, and freezer boxes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.